Cerity Partners
VIR icon

Cerity Partners’s Vir Biotechnology VIR Stock Holding History

Cerity Partners’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Buy
35,864
+19,775
+123% +$158K ﹤0.01% 2564
2025
Q4 		$97K Sell
16,089
-1,738
-10% -$10.3K ﹤0.01% 2751
2025
Q3 		$102K Sell
17,827
-16,076
-47% -$82.2K ﹤0.01% 2625
2025
Q2 		$171K Buy
33,903
+18,882
+126% +$101K ﹤0.01% 2394
2025
Q1 		$97.3K Buy
+15,021
New +$134K ﹤0.01% 2325
2024
Q4 		– Sell
-16,435
Closed -$123K – 2606
2024
Q3 		$123K Buy
+16,435
New +$143K ﹤0.01% 2406
2024
Q2 		– Sell
-11,642
Closed -$118K – 2416
2024
Q1 		$118K Buy
+11,642
New +$119K ﹤0.01% 2186

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Cerity Partners's VIR Position: Q1 2026 in Review

Cerity Partners increased its Vir Biotechnology (VIR) stake by 123% in Q1 2026, buying an estimated $158K and bringing the position to 35,864 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Cerity Partners first reported a position in VIR in Q1 2024 and has held it in 7 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Cerity Partners held 35,864 shares of Vir Biotechnology worth $321K as of Q1 2026.
  • Cerity Partners bought 19,775 Vir Biotechnology shares in Q1 2026, an estimated $158K.
  • Vir Biotechnology made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2564 holding.
  • Cerity Partners first reported a position in Vir Biotechnology in Q1 2024 and has held it in 7 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.